Cutaneous squamous cell carcinoma metastatic to parotid - analysis of prognostic factors and treatment outcome
- PMID: 22731750
- PMCID: PMC3422189
- DOI: 10.1186/1477-7819-10-117
Cutaneous squamous cell carcinoma metastatic to parotid - analysis of prognostic factors and treatment outcome
Abstract
Background: Cutaneous squamous cell carcinoma (cSCC) comprises 20% of all skin cancer of the head and neck. A minority will metastasize to regional parotid lymph nodes. This study evaluates the St Vincent's Hospital, Sydney experience between 1996 and 2006.
Methods: A retrospective review was performed of patients who were evaluated in our multidisciplinary head and neck clinic with metastatic cSCC to parotid, and all treatment and pathologic details were reviewed. Statistical analysis, including univariate and multivariate analyses, were performed using Cox proportional hazards regression mode, overall and disease-specific survival were estimated by the Kaplan-Meier method.
Results: Sixty-seven patients were identified. Some 90 % were male, and with a mean age of 72.8 years. One died on the first postoperative day. The remaining 66 patients received radiotherapy. For these 66 patients, the two-year and five-year overall survival rate was 0.83 and 0.72, respectively. The two-year and five-year disease-free survival rate was 0.91 and 0.83 respectively. Overall survival was only significantly correlated to the extent of parotidectomy (superficial versus total; P = 0.0256). Margin status was available in 59 patients. The only parameter that significantly correlated with disease-free survival was margin status (close/negative versus positive P = 0.0348). Other parameters of immune suppression, perineural invasion, extra capsular extension, degree of tumour differentiation, number of positive nodes, extent of neck dissection and radiotherapy dosage delivered did not confer prognostic significance.
Conclusions: This study confirmed the association of adverse prognostic implication of positive margins on disease-free survival. Immune compromise was not a significant factor in this small group. Further studies are warranted in this population.
Figures




Similar articles
-
Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.J Plast Reconstr Aesthet Surg. 2006;59(12):1288-93. doi: 10.1016/j.bjps.2006.03.043. Epub 2006 Jun 5. J Plast Reconstr Aesthet Surg. 2006. PMID: 17113505
-
Head and neck cutaneous squamous cell carcinoma requiring parotidectomy: prognostic indicators and treatment selection.Otolaryngol Head Neck Surg. 2014 Apr;150(4):610-7. doi: 10.1177/0194599814520686. Epub 2014 Jan 28. Otolaryngol Head Neck Surg. 2014. PMID: 24474713
-
Prognostic factors for metastatic cutaneous squamous cell carcinoma of the parotid.J Otolaryngol Head Neck Surg. 2013 Feb 5;42(1):14. doi: 10.1186/1916-0216-42-14. J Otolaryngol Head Neck Surg. 2013. PMID: 23663562 Free PMC article.
-
Elective neck dissection in metastatic cutaneous squamous cell carcinoma to the parotid gland: A systematic review and meta-analysis.Head Neck. 2019 Apr;41(4):1131-1139. doi: 10.1002/hed.25561. Epub 2018 Dec 7. Head Neck. 2019. PMID: 30536662
-
Management of regional metastatic disease in head and neck cutaneous malignancy. 1. Cutaneous squamous cell carcinoma.Br J Oral Maxillofac Surg. 2014 Apr;52(4):294-300. doi: 10.1016/j.bjoms.2014.01.015. Epub 2014 Feb 20. Br J Oral Maxillofac Surg. 2014. PMID: 24559975 Review.
Cited by
-
Circulating tumour cells in regionally metastatic cutaneous squamous cell carcinoma: A pilot study.Oncotarget. 2016 Jul 26;7(30):47111-47115. doi: 10.18632/oncotarget.9946. Oncotarget. 2016. PMID: 27302928 Free PMC article.
-
Parotidectomy and neck dissection in locally advanced and relapsed cutaneous squamous cell carcinoma of the head and neck region.Braz J Otorhinolaryngol. 2022 Nov-Dec;88 Suppl 4(Suppl 4):S152-S162. doi: 10.1016/j.bjorl.2021.11.007. Epub 2021 Dec 10. Braz J Otorhinolaryngol. 2022. PMID: 35042657 Free PMC article.
-
Determinants of Prognosis in Head and Neck Cutaneous Squamous Cell Carcinoma With Nodal Metastases.JAMA Otolaryngol Head Neck Surg. 2024 Nov 1;150(11):986-994. doi: 10.1001/jamaoto.2024.3103. JAMA Otolaryngol Head Neck Surg. 2024. PMID: 39325436
-
Metastatic Cutaneous Squamous Cell Carcinoma Involving the Parotid Gland: Experience Outside of the Sun Belt.OTO Open. 2021 Jan 8;5(1):2473974X20984720. doi: 10.1177/2473974X20984720. eCollection 2021 Jan-Mar. OTO Open. 2021. PMID: 33474523 Free PMC article.
-
Parotid Gland Metastases of Cutaneous Squamous Cell Carcinoma of the Head: Occult Metastases Occurrence and Their Late Manifestation.Int J Clin Pract. 2024 Feb 19;2024:5525741. doi: 10.1155/2024/5525741. eCollection 2024. Int J Clin Pract. 2024. PMID: 38410673 Free PMC article.
References
-
- Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006;184:6–10. - PubMed
-
- Australian cancer incidence and mortality workbooks (ACIM) AIHW, Canberra; 2010. Retrieved from [ www.aihw.gov.au/cancer/data/acim_books/index.cfm] on 13 October 2011.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical